Read this article:
Selecta Biosciences to Host Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Business Update

See the rest here:
Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy

See the article here:
Bio-Path Holdings to Announce Third Quarter 2021 Financial Results on November 12, 2021

Here is the original post:
Orchestra BioMed™ Announces Presentations at TCT 2021 of Positive Long-Term Clinical Results from the MODERATO II Study Showing the Significant...

Go here to read the rest:
Coherus BioSciences Announces CMS Has Extended Enhanced Medicare Reimbursement for UDENYCA® in the 340B Hospital Setting Through Year-End 2022

View original post here:
Longeveron Selects Clinical Research Organization for Phase 2 Alzheimer’s Disease Trial

Read more:
Wegovy™ demonstrated significant and sustained weight loss in two-year study in adults with obesity

Originally posted here:
Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes

Eye IRPL® device specifically designed to treat evaporative dry eye due to meibomian gland dysfunction.]]>

Go here to see the original:
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.

Link:
PAOG Announces Plans To Add New Pharmaceutical Product Developments

Read more:
MYNZ Shares Have Commenced Trading on the Nasdaq Capital Market

Continue reading here:
Bavarian Nordic to Host Third Quarter 2021 Results Conference Call

See the original post:
Tauriga Sciences, Inc. Reports Continued Strength and Accelerating Growth in its Highest Margin E-Commerce Business Segment

More:
Monthly information related to total number of voting rights and shares composing the share capital – October 30, 2021

The rest is here:
CORRECTING AND REPLACING: Eyenovia to Report Third Quarter 2021 Results on Wednesday, November 10

Read more here:
TFF Pharmaceuticals to Hold Third Quarter 2021 Financial and Business Results Conference Call on November 15, 2021

Read the original here:
MYNZ Closes Its First Day of Trading on the Nasdaq Capital Market

Continued here:
atai Life Sciences to Participate in Upcoming November Investor Conferences

See more here:
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021

See original here:
Avicanna Announces Management Change